Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Samadzadeh

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of the Neurological Sciences|April 1, 2015
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patientsSara Samadzadeh, Elnaz Tabibian, Tayebeh Sabokbar, et al.
Journal of Neurology|July 17, 2022
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystoniaHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Toxins|January 20, 2022
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment FailureHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2025
Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGADFiona Chan, David Berhanu, Sara Samadzadeh, et al.
Journal of the Neurological Sciences|July 28, 2014
Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in IranRoya Abolfazli, Sara Samadzadeh, Tayebeh Sabokbar, et al.
Iranian Journal of Psychiatry|September 7, 2012
The effects of chronic partial sleep deprivation on cognitive functions of medical residentsHabibolah Khazaie, Masoud Tahmasian, Mohammad R Ghadami, et al.
Journal of Neurology|June 10, 2025
The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGADSara Samadzadeh, Fiona Chan, Anna Francis, et al.
Clinical Neurology and Neurosurgery|September 13, 2024
The patient-reported outcomes for the new brand-generic teriflunomide in relapsing-remitting multiple sclerosisRoya Abolfazli, Seyed Massood Nabavi, Amirreza Azimi, et al.
Frontiers in Immunology|April 29, 2026
E-based physical exercise in patients with multiple sclerosis and comorbidity (COMPACT): feasibility study and protocol for a randomized controlled trialRafl Adnan, Sara Samadzadeh, Camilla Richter, et al.
Biomolecules|December 23, 2022
Pseudocholinesterase as a Biomarker for Untreated Wilson's DiseaseHarald Hefter, Max Arslan, Theodor S Kruschel, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of the Neurological Sciences|April 1, 2015
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patientsSara Samadzadeh, Elnaz Tabibian, Tayebeh Sabokbar, et al.
Journal of Neurology|July 17, 2022
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystoniaHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Toxins|January 20, 2022
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment FailureHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2025
Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGADFiona Chan, David Berhanu, Sara Samadzadeh, et al.
Journal of the Neurological Sciences|July 28, 2014
Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in IranRoya Abolfazli, Sara Samadzadeh, Tayebeh Sabokbar, et al.
Iranian Journal of Psychiatry|September 7, 2012
The effects of chronic partial sleep deprivation on cognitive functions of medical residentsHabibolah Khazaie, Masoud Tahmasian, Mohammad R Ghadami, et al.
Journal of Neurology|June 10, 2025
The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGADSara Samadzadeh, Fiona Chan, Anna Francis, et al.
Clinical Neurology and Neurosurgery|September 13, 2024
The patient-reported outcomes for the new brand-generic teriflunomide in relapsing-remitting multiple sclerosisRoya Abolfazli, Seyed Massood Nabavi, Amirreza Azimi, et al.
Frontiers in Immunology|April 29, 2026
E-based physical exercise in patients with multiple sclerosis and comorbidity (COMPACT): feasibility study and protocol for a randomized controlled trialRafl Adnan, Sara Samadzadeh, Camilla Richter, et al.
Biomolecules|December 23, 2022
Pseudocholinesterase as a Biomarker for Untreated Wilson's DiseaseHarald Hefter, Max Arslan, Theodor S Kruschel, et al.
Pageof 8